Please Wait.....
Report
Animal Drugs Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034
Market Report I 2025-02-21 I 155 Pages I Global Market Insights
The Global Animal Drugs Market reached USD 43.3 billion in 2024 and is projected to register a CAGR of 6.1% from 2025 to 2034. The market growth is driven by a combination of rising pet ownership, increasing demand for livestock healthcare, and advancements in veterinary medicine. As more people embrace pets as companions, the need for high-quality pharmaceuticals to address a wide range of health conditions is surging.
Likewise, the livestock industry is witnessing a growing emphasis on disease prevention and productivity enhancement, fueling demand for specialized drugs. The rising prevalence of chronic diseases in animals, including arthritis, diabetes, and cardiovascular disorders, is pushing veterinary expenditures higher, prompting the development of more effective treatment options. Increasing awareness about preventive care, coupled with regulatory approvals for innovative veterinary pharmaceuticals, is further accelerating market growth. With ongoing R&D efforts and improved accessibility to veterinary care, the industry is poised for continued expansion.
Pharmaceutical innovations, in line with improved distribution networks, are making animal drugs more accessible across regions. Governments and private organizations are actively supporting veterinary research, leading to the introduction of advanced therapeutics designed to minimize recovery time and enhance overall animal well-being. Additionally, a surge in pet insurance coverage is encouraging pet owners to invest in high-quality medications, ensuring better treatment adherence.
The drugs segment led the market in 2024 with USD 23.8 billion, dominating due to its essential role in treating infections, inflammation, and parasitic infestations. Veterinary pharmaceuticals are increasingly being formulated to provide targeted treatment, reducing side effects and improving efficacy. The rising incidence of zoonotic diseases is also reinforcing the demand for advanced medications, prompting pharmaceutical companies to invest in cutting-edge research. Pet owners are becoming more proactive about their animals' health, opting for prescription medications that offer faster recovery and long-term benefits. Growing concerns over antimicrobial resistance are driving the adoption of alternative treatments, including probiotics and immunomodulators, further diversifying the drug landscape.
Companion animals accounted for 59.2% of the market share in 2024, reflecting the increasing number of households adopting pets and prioritizing their medical care. Rising disposable income, coupled with an emotional attachment to pets, is leading to higher veterinary spending, particularly on specialized medications. The demand for preventative treatments, including vaccines and nutritional supplements, is surging as pet owners seek to enhance their animals' longevity and quality of life. Technological advancements in veterinary diagnostics are also playing a key role in the segment's growth, enabling early disease detection and personalized treatment approaches.
North America accounted for 41.4% of the market share in 2024, maintaining its dominance due to high pet ownership rates and a well-established veterinary healthcare system. The region's significant livestock industry continues to drive demand for pharmaceuticals aimed at improving herd health and productivity. Expanding research initiatives, combined with growing regulatory support for innovative veterinary treatments, are reinforcing industry growth. The increasing availability of advanced treatment options, such as biologics and gene-based therapies, is shaping the future of animal healthcare, ensuring sustained demand for pharmaceuticals across the region.
Report Content
Chapter 1 Methodology and Scope
1.1 Market scope and definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates and calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 360 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of animal diseases
3.2.1.2 Growing focus on livestock productivity
3.2.1.3 Surging demand for pet insurance policies
3.2.1.4 Growing government initiatives and support towards animal welfare
3.2.1.5 Intensified R&D activities drive advancements in veterinary medicine
3.2.1.6 Expanding online veterinary pharmacies
3.2.2 Industry pitfalls and challenges
3.2.2.1 Adverse side effects and drug recalls
3.2.2.2 High cost associated with animal drugs development
3.3 Growth potential analysis
3.4 Regulatory landscape
3.4.1 North America
3.4.2 Europe
3.4.3 Asia Pacific
3.5 Policy landscape
3.6 Product pipeline analysis
3.7 Investor overview
3.8 GAP analysis
3.9 Consumer behaviour trends
3.10 Porter's analysis
3.11 PESTEL analysis
Chapter 4 Competitive Landscape, 2024
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)
5.1 Key trends
5.2 Drugs
5.2.1 Antiparasitic
5.2.2 Anti-inflammatory
5.2.3 Anti-infectives
5.2.4 Corticosteroids
5.2.5 Tranquilizers
5.2.6 Cardiovascular drugs
5.2.7 Gastrointestinal drugs
5.3 Vaccines
5.3.1 Modified live vaccines (MLV)
5.3.2 Killed inactivated vaccines
5.3.3 Recombinant vaccines
5.4 Medicated feed additives
5.4.1 Antibiotics
5.4.2 Vitamins
5.4.3 Amino acids
5.4.4 Enzymes
5.4.5 Antioxidants
5.4.6 Prebiotics and probiotics
5.4.7 Minerals
5.4.8 Other medicated feed additives
Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)
6.1 Key trends
6.2 Companion animals
6.2.1 Dogs
6.2.2 Cats
6.2.3 Horses
6.2.4 Other companion animals
6.3 Livestock animals
6.3.1 Poultry
6.3.2 Swine
6.3.3 Cattle
6.3.4 Fish
6.3.5 Other livestock animals
Chapter 7 Market Estimates and Forecast, By Route of Administration, 2021 - 2034 ($ Mn)
7.1 Key trends
7.2 Oral
7.3 Injectable
7.4 Topical
7.5 Other routes of administration
Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2021 - 2034 ($ Mn)
8.1 Key trends
8.2 Veterinary hospital pharmacies
8.3 E-commerce
8.4 Retail pharmacies
Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Spain
9.3.5 Italy
9.3.6 Poland
9.3.7 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Taiwan
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 GCC Countries
9.6.3 Israel
Chapter 10 Company Profiles
10.1 Agrolabo
10.2 Boehringer Ingelheim International
10.3 Ceva Sante Animale
10.4 Chanelle Pharma
10.5 Dechra Pharmaceuticals
10.6 Durvet
10.7 Elanco Animal Health
10.8 Endovac Animal Health
10.9 HIPRA
10.10 Indian Immunologicals
10.11 Merck
10.12 Norbrook
10.13 Neogen Corporation
10.14 Symrise
10.15 Vetoquinol
10.16 Virbac
10.17 Zoetis
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security